| Arno Therapeutics is a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs |
| ![]() |
July 19, 2011 Veterans of J&J, Pfizer, and Medimmune Seek to Transform Arno into Oncology Powerhouse xconomy.com June 27, 2011 Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer more » June 23, 2011 Arno Therapeutics Reports Positive Interim Results from Glioblastoma Study; Phase II Enrollment to Continue more » April 28, 2011 Arno Therapeutics Announces the Appointment of Mr. Glenn Mattes as President and Chief Executive Officer more » |
More to come... |
Arno Therapeutics, Inc. 200 Route 31 North Suite 104 Flemington, NJ 08822 (862) 703-7170 Main (973) 267-0101 Fax info@arnothera.com |
©2011 Arno Therapeutics, Inc. | Privacy Policy |